MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 297 filers reported holding MEDIVATION INC in Q3 2014. The put-call ratio across all filers is 1.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $20,693,000 | +148.1% | 343,185 | +89.2% | 0.06% | +150.0% |
Q1 2016 | $8,341,000 | -31.4% | 181,407 | -27.9% | 0.03% | -25.7% |
Q4 2015 | $12,164,000 | -55.6% | 251,614 | -60.9% | 0.04% | -58.3% |
Q3 2015 | $27,370,000 | -21.7% | 643,989 | +110.5% | 0.08% | -2.3% |
Q2 2015 | $34,936,000 | -8.9% | 305,923 | +2.9% | 0.09% | -5.5% |
Q1 2015 | $38,360,000 | +252.8% | 297,203 | +172.3% | 0.09% | +237.0% |
Q4 2014 | $10,873,000 | +20.4% | 109,157 | +19.5% | 0.03% | +22.7% |
Q3 2014 | $9,030,000 | +19.5% | 91,334 | -6.8% | 0.02% | +15.8% |
Q2 2014 | $7,557,000 | -12.8% | 98,044 | -27.2% | 0.02% | -24.0% |
Q1 2014 | $8,667,000 | +24.4% | 134,644 | +23.3% | 0.02% | +19.0% |
Q4 2013 | $6,969,000 | -15.6% | 109,203 | -20.7% | 0.02% | -30.0% |
Q3 2013 | $8,253,000 | +29.9% | 137,680 | +6.6% | 0.03% | +11.1% |
Q2 2013 | $6,355,000 | – | 129,165 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
QVT Financial LP | 547,628 | $26,943,000 | 1.81% |